Cost-Effectiveness of Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation in Hong Kong.

Kuan Peng,Yihua Li,Esther W Chan,Ian C K Wong,Xue Li

Value in health regional issues（2023）

引用 0|浏览7

暂无评分

摘要

Apixaban was the most cost-effective option compared with other DOACs and warfarin in the management of NVAF; this conclusion is consistent under all the tested uncertainty scenarios.

查看译文

关键词

Markov model,anticoagulation,atrial fibrillation,cost-effectiveness analysis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要